Home2496 • HKG
add
Wuhan YZY Biopharma Co Ltd
Previous close
$7.86
Year range
$4.00 - $8.02
Market cap
1.52B HKD
Avg Volume
160.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 22.18M | 1,464.49% |
Operating expense | 36.14M | -13.29% |
Net income | -29.42M | 24.95% |
Net profit margin | -132.60 | 95.20% |
Earnings per share | — | — |
EBITDA | -27.67M | 28.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 166.18M | 2.68% |
Total assets | 239.63M | -7.82% |
Total liabilities | 267.07M | 26.95% |
Total equity | -27.44M | — |
Shares outstanding | 193.85M | — |
Price to book | -56.14 | — |
Return on assets | -29.95% | — |
Return on capital | -55.55% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -29.42M | 24.95% |
Cash from operations | 6.10M | 120.98% |
Cash from investing | 145.50K | 106.45% |
Cash from financing | 13.46M | -3.31% |
Net change in cash | 19.95M | 214.57% |
Free cash flow | -17.61M | 28.08% |
About
Founded
2010
Website
Employees
106
